// App-Quantinova.ai

[FRI0593] : EFFECTS OF NEW (DIRECT) ORAL ANTICOAGULANTS ON LUPUS ANTICOAGULANT ASSAYS

Researchers

Presenter

  • J. Antovic

Principal Investigators

  • A. Antovic

  • E.M. Norberg

  • M. Berndtsson

  • M. Skeppholm

Medical Centers

  • Department of Medicine, Clinical Pharmacology Unit, Division of Cardiovascular Medicine, Karolinska Institutet & Danderyd Hospital, Stockholm, Sweden

Locations

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Antiphospholipid syndrome

  • Venous thrombosis

  • Arrhythmia

  • Lupus

Biomarkers

  • Activated partial thromboplastin time

Drug/Treatment

  • rivaroxaban

  • Pradax

  • apixaban

  • Evithrom

  • Warfarin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved